The ret/PTC mutations are common in sporadic papillary thyroid carcinoma of children and young adults

被引:185
作者
Fenton, CL
Lukes, Y
Nicholson, D
Dinauer, CA
Francis, GL
Tuttle, RM
机构
[1] Mem Sloan Kettering Canc Ctr, Endocrine Serv, New York, NY 10021 USA
[2] Walter Reed Army Med Ctr, Dept Pediat, Washington, DC 20307 USA
[3] Walter Reed Army Med Ctr, Dept Clin Invest, Washington, DC 20307 USA
[4] Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Bethesda, MD 20814 USA
[5] Mem Sloan Kettering Canc Ctr, Endocrine Serv, New York, NY 10021 USA
关键词
D O I
10.1210/jc.85.3.1170
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The ret/PTC rearrangements (PTC-1, PTC-3, and PTC-3) are characteristic of papillary thyroid cancer (PTC). In adults, PTC-1 is common and may be associated with an aggressive clinical course. The incidence and significance of ret/PTC mutations are less well understood in children. We examined spontaneous PTC from 33 patients (23 females and 10 males) with a median age of 18 yr (range, 6-21 yr) and a median follow-up of 3.5 yr (range, 0-13.4 yr). The ret/PTC mutations were identified in 15 tumors (45%), including 8 PTC-1 (8 of 15, 53%), 2 PTC-P (2 of 15, 13%), 2 PTC-3 (2 of 15, 13%), and 3 13 df 15, 20%) combined PTC mutations (PTC-1 and PTC-P). This distribution is significantly different (P = 0.001, by chi(2) analysis) from that reported for children with radiation-induced PTC. There was no correlation between the presence or type of ret/PTC mutation and patient age, tumor size, focality, extent of disease at diagnosis, or recurrence. We conclude that ret/PTC mutations are 1) common in sporadic childhood PTC, 2) predominantly PTC-1, 3) frequently multiple, and 4) of different distribution than that reported for children with radiation-induced PTC.
引用
收藏
页码:1170 / 1175
页数:6
相关论文
共 17 条
[1]  
Bongarzone I, 1998, CLIN CANCER RES, V4, P223
[2]   Age-related activation of the tyrosine kinase receptor protooncogenes RET and NTRK1 in papillary thyroid carcinoma [J].
Bongarzone, I ;
Fugazzola, L ;
Vigneri, P ;
Mariani, L ;
Mondellini, P ;
Pacini, F ;
Basolo, F ;
Pinchera, A ;
Pilotti, S ;
Pierotti, MA .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (05) :2006-2009
[3]   NATURAL-HISTORY, TREATMENT, AND COURSE OF PAPILLARY THYROID-CARCINOMA [J].
DEGROOT, LJ ;
KAPLAN, EL ;
MCCORMICK, M ;
STRAUS, FH .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1990, 71 (02) :414-424
[4]   Ret and trk proto-oncogene activation in thyroid papillary carcinomas in French patients from the Champagne-Ardenne region [J].
Delvincourt, C ;
Patey, M ;
Flament, JB ;
Suarez, HG ;
Larbre, H ;
Jardillier, JC ;
Delisle, MJ .
CLINICAL BIOCHEMISTRY, 1996, 29 (03) :267-271
[5]   Clinical features associated with metastasis and recurrence of differentiated thyroid cancer in children, adolescents and young adults [J].
Dinauer, CAW ;
Tuttle, RM ;
Robie, DK ;
McClellan, DR ;
Svec, RL ;
Adair, C ;
Francis, GL .
CLINICAL ENDOCRINOLOGY, 1998, 49 (05) :619-628
[6]  
FUGAZZOLA L, 1995, CANCER RES, V55, P5617
[7]  
Klugbauer S, 1995, ONCOGENE, V11, P2459
[8]   RET/PTC and RET tyrosine kinase expression in adult papillary thyroid carcinomas [J].
Learoyd, DL ;
Messina, M ;
Zedenius, J ;
Guinea, AI ;
Delbridge, LW ;
Robinson, BG .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (10) :3631-3635
[9]   High frequency of rearrangement of the RET protooncogene (RET/PTC) in Chinese papillary thyroid carcinomas [J].
Lee, CH ;
Hsu, LS ;
Chi, CW ;
Chen, GD ;
Yang, AH ;
Chen, JY .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (05) :1629-1632
[10]  
Mayr B, 1997, J CLIN ENDOCR METAB, V82, P1306, DOI 10.1210/jc.82.4.1306